Jointown Pharmaceutical Group announced that its subsidiary Shandong Jingfeng Pharmaceutical's furosemide chemical raw material pharmaceutical has obtained the approval of the National Medical Products Administration for marketing. Furosemide is a potent diuretic mainly used to treat edema caused by diseases of the heart, liver, and kidneys.
九州通：子公司呋塞米化学原料药获上市批准
Jointown Pharmaceutical Group: Subsidiary Fursultiamine Active Pharmaceutical Ingredient Obtains Market Approval.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated